Skip to main content

Consumer Reports Rates Best Sunscreen Buys


May 25, 2012 — With any luck, the Memorial Day weekend will bring weather good enough to be slathering on the sunscreen at least every two hours when outdoors.
And to know which are the best products to put on your skin during the unofficial start of summer, the May issue ofConsumer Reports rated 18 top-selling sunscreens. The products ranged from SPF 30 to SPF 75+ and were lotions, sprays, or a spray foam. They varied in price from a low of $.59 an ounce to a high of $20.59 per ounce.
To judge the performance of each product, sunscreens were tested on people, and the ultraviolet B (UVB) radiation protection was rated before and after swimming in fresh water for up to 80 minutes. Testers also checked whether the product stained clothing.
In addition, they did a new "critical wavelength" test required by the FDA to see if the sunscreen truly offered broad-spectrum UVA and UVB protection. UVB radiation is the main cause of sunburn, while UVA rays penetrate deeper, where they can cause long-term damage and age skin.
Top 7 Sunscreens
Most products offered good UVB protection, while many helped block UVA rays.
The cheapest sunscreen outscored the most expensive product in the test, leading researchers to conclude that "price had nothing to do with performance."
After testing, Consumer Reports named three of its highest-rated sunscreens as "Best Buys," while four other top-scoring products were "Recommended."
Best Buys
  • No-Ad lotion with aloe &vitamin E, SPF 45, $.59/ounce
  • Walgreens continuous spray sport, SPF 50, $1.30/ounce
  • Coppertone oil-free foaming spray, SPF 75+, $1.67/ounce
Recommended
  • All Terrain Aqua Sport lotion, SPF 30, $4/ounce
  • Banana Boat clear ultra-mist sports performance active dry protect spray, SPF 30, $1.63/ounce
  • Coppertone sport high performance ultra sweat-proof spray, SPF 30, $1.67/ounce
  • Eco all natural sunscreen body lotion, SPF 30, $4.72/ounce
Two sunscreens flunked the "broad spectrum" test:
  • Alba Botanical natural very emollient sunblock sport, SPF 45
  • Banana Boat Kids tear-free, sting-free, SPF 50+
No matter which product you put on, Consumer Reports offered these tips to help stay safe in the sun:
  • Choose a waterproof sunscreen with at least an SPF of 30. Above 30 provided little extra protection.
  • Use 2 to 3 tablespoons of sunscreen; reapply every two hours and after swimming or sweating.
  • Wear a hat and protective clothing in addition to using sunscreen.
  • The FDA is looking into possible risks of inhaling spray sunscreens. Consumer Reports recommends avoiding using sprays on kids. If used, spray on hands first before applying to the face.
  • The group also recommends that pregnant women may want to avoid products with retinyl palmitate.
Read labels and ingredients carefully. New FDA requirements for sunscreens and other cosmetic products containing an SPF value will soon make it easier for consumers to understand the labels and what claims, such as "broad spectrum" or "water-resistance," really mean.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...